Processa Pharmaceuticals, Inc.·4/A

Oct 23, 5:31 PM ET

Yorke Justin W 4/A

4/A · Processa Pharmaceuticals, Inc. · Filed Oct 23, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-10-12
Transactions
  • Award

    Common Stock

    2023-10-12$0.30/sh+6,000$1,80074,729 total
Holdings
  • Common Stock

    (indirect: By LLC)
    519,890
Footnotes (1)
  • [F1]Amendment filed solely to correct the amount directly owned reported on the Form 4 filed October 12, 2023 and the Form 4 filed on October 10/10/2023.

Documents

1 file
  • 4
    form4.xml